The global smart medical devices market size is calculated at USD 59.26 billion in 2025 and is forecasted to reach around USD 168 billion by 2034, accelerating at a CAGR of 12.30% from 2025 to 2034. The North America smart medical devices market size surpassed USD 21.91 billion in 2024 and is expanding at a CAGR of 12.31% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Smart Medical Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Smart Medical Devices Market Revenue and Volume Forecast, by Product
8.1.1. Diagnostics and Monitoring
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Therapeutics Devices
8.1.2.1. Market Revenue and Volume Forecast
9.1. Smart Medical Devices Market Revenue and Volume Forecast, by End-User
9.1.1. Homecare Settings
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Hospitals
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast
10.1. Smart Medical Devices Market Revenue and Volume Forecast, by Modality
10.1.1. Portable
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Wearable
10.1.2.1. Market Revenue and Volume Forecast
11.1. Smart Medical Devices Market Revenue and Volume Forecast, by Distribution Channel
11.1.1. Pharmacies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Online Channel
11.1.2.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product
12.1.2. Market Revenue and Volume Forecast, by End-User
12.1.3. Market Revenue and Volume Forecast, by Modality
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product
12.1.5.2. Market Revenue and Volume Forecast, by End-User
12.1.5.3. Market Revenue and Volume Forecast, by Modality
12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product
12.1.6.2. Market Revenue and Volume Forecast, by End-User
12.1.6.3. Market Revenue and Volume Forecast, by Modality
12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product
12.2.2. Market Revenue and Volume Forecast, by End-User
12.2.3. Market Revenue and Volume Forecast, by Modality
12.2.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product
12.2.5.2. Market Revenue and Volume Forecast, by End-User
12.2.5.3. Market Revenue and Volume Forecast, by Modality
12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product
12.2.6.2. Market Revenue and Volume Forecast, by End-User
12.2.6.3. Market Revenue and Volume Forecast, by Modality
12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product
12.2.7.2. Market Revenue and Volume Forecast, by End-User
12.2.7.3. Market Revenue and Volume Forecast, by Modality
12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product
12.2.8.2. Market Revenue and Volume Forecast, by End-User
12.2.8.3. Market Revenue and Volume Forecast, by Modality
12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product
12.3.2. Market Revenue and Volume Forecast, by End-User
12.3.3. Market Revenue and Volume Forecast, by Modality
12.3.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product
12.3.5.2. Market Revenue and Volume Forecast, by End-User
12.3.5.3. Market Revenue and Volume Forecast, by Modality
12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product
12.3.6.2. Market Revenue and Volume Forecast, by End-User
12.3.6.3. Market Revenue and Volume Forecast, by Modality
12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product
12.3.7.2. Market Revenue and Volume Forecast, by End-User
12.3.7.3. Market Revenue and Volume Forecast, by Modality
12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product
12.3.8.2. Market Revenue and Volume Forecast, by End-User
12.3.8.3. Market Revenue and Volume Forecast, by Modality
12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product
12.4.2. Market Revenue and Volume Forecast, by End-User
12.4.3. Market Revenue and Volume Forecast, by Modality
12.4.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product
12.4.5.2. Market Revenue and Volume Forecast, by End-User
12.4.5.3. Market Revenue and Volume Forecast, by Modality
12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product
12.4.6.2. Market Revenue and Volume Forecast, by End-User
12.4.6.3. Market Revenue and Volume Forecast, by Modality
12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product
12.4.7.2. Market Revenue and Volume Forecast, by End-User
12.4.7.3. Market Revenue and Volume Forecast, by Modality
12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product
12.4.8.2. Market Revenue and Volume Forecast, by End-User
12.4.8.3. Market Revenue and Volume Forecast, by Modality
12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product
12.5.2. Market Revenue and Volume Forecast, by End-User
12.5.3. Market Revenue and Volume Forecast, by Modality
12.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product
12.5.5.2. Market Revenue and Volume Forecast, by End-User
12.5.5.3. Market Revenue and Volume Forecast, by Modality
12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product
12.5.6.2. Market Revenue and Volume Forecast, by End-User
12.5.6.3. Market Revenue and Volume Forecast, by Modality
12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel
13.1. Abbott
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Apple, Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Fitbit, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Dexcom, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. F. Hoffmann-La Roche Ltd
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Zephyr
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sonova, NeuroMetrix, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Medtronic
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Johnson & Johnson
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample